A historic crush of holiday packages is causing widespread delays and gridlock at the U.S. Postal Service, made worse by the service’s inability to turn down shipments like rival private competitors UPS and FedEx.
The Port of Los Angeles approved a first-of-its kind Port Cyber Resilience Center to protect against cyberattacks that could disrupt port activity and cargo flow.
Malware in the form of fake delivery notices from Amazon, UPS and FedEx is up 440% this year as hackers take advantage of rising e-commerce to penetrate computer systems and steal personal information.
Logistics conditions continue to deteriorate, with trucking demand exceeding availability, growing congestion at ports, and backlogs at warehousing and packaging facilities due in part to operating challenges related to the pandemic. Shipping containers are in short supply, with demurrage charges rising. Clients are advised to provide expanded lead times on orders to help ensure delivery dates.
The U.S. recorded 190,519 new COVID-19 cases and 1,696 deaths yesterday, pushing total infections above 18 million.
California has no more ICU beds available in the Los Angeles area and the San Joaquin Valley agricultural region, the governor said yesterday, adding that the state could face an unprecedented 100,000 total hospitalizations in January due to rising COVID-19 infections verging on 40,000 to 50,000 new cases per day.
Texas suffered a record in daily COVID-19 infections last Thursday, and hospitalizations topped 10,000 for the first time since a summer peak, prompting the governor to receive a public vaccination shot.
U.S. health officials say there is no reason to believe the efficacy of COVID-19 vaccines will be reduced by a new, highly infectious coronavirus variant that recently appeared in the U.K. Scientists from BioNTech, Pfizer’s partner in one of the world’s most successful vaccines so far, say their vaccine is just as effective against the new strain in the U.K.
New York will require inbound air passengers from the U.K. to be pre-screened for COVID-19 before boarding flights on three major carriers.
The arrival of COVID-19 vaccines has prompted a hiring frenzy among pharmacies and supermarkets engaged in their distribution.
Several medical companies are putting resources into developing treatments for “long-haul” COVID-19 symptoms, a mystifying occurrence that prolongs several side effects — including brain fog, extreme fatigue and shortness of breath — in 10% to 20% of infected people.
Guitar Center, the nation’s largest seller of musical instruments, will go into and out of bankruptcy in less than a month on expected approval of plans to cut $800 million in debt through cash infusions.
Nike’s digital revenue increased 84% in the quarter ended November 30, a confirmation of the company’s recent strategy shifts toward e-commerce activity.
Apple is aiming to produce self-driving cars by 2024, helped in part by in-house battery technology that could reduce costs of power packs and extend the vehicle’s range.
Ontario, Canada’s largest province, will impose regional lockdowns starting the day after Christmas, with officials saying COVID-19 transmissions are moving toward dangerous territory.
Australian officials are working to contain a cluster of 83 COVID-19 cases in Greater Sydney with bans on travel outside the region and increased restrictions posed on residents yesterday. Contact tracing used to isolate the cases appears to be working, as the region reported only eight new cases of locally acquired COVID-19 in the past 24 hours, down from 15 the prior day.
South African officials are warning that rising COVID-19 rates are putting the nation’s hospital resources and available beds under increasing strain.
The European Union came one step closer to approving Pfizer/BioNTech’s COVID-19 vaccine, with final authorization expected to come from regulators later this week. Pfizer/BioNTech are already beginning to ship out refrigerated cargo trucks carrying hundreds of thousands of vaccine doses to the bloc’s 27 nations.
Pfizer and German partner BioNTech are rapidly exploring ways to produce more than the 1.3 billion COVID-19 vaccines promised to countries in 2021.
Brazil became the first country to complete Phase 3 trials of China-developed Sinovac Biotech’s COVID-19 vaccine, reporting a greater than 50% efficacy rate, enough for Brazilian regulators to approve the drug for use.
M. Holland will be closed on Thursday and Friday, December 24 and 25, for the Christmas holiday. We will be closed Friday, January 1, for New Year’s Day.
Market Expertise: M. Holland offers a host of resources to clients, prospects and suppliers across nine strategic markets. To arrange a videoconference or meeting with any of our Market Managers, please visit our website.
To access 3D Printing training, order parts and seek technical assistance, visit our online resource.
M. Holland Company
We will provide further COVID-19 bulletins as circumstances dictate. For all COVID-19 updates and notices, please refer to the M. Holland website.